1 Swine Atrophic Rhinitis Vaccine Market Overview 1.1 Product Overview and Scope of Swine Atrophic Rhinitis Vaccine 1.2 Swine Atrophic Rhinitis Vaccine Segment by Activity 1.2.1 Global Swine Atrophic Rhinitis Vaccine Sales Growth Rate Comparison by Activity (2022-2028) 1.2.2 Swine Atrophic Rhinitis Vaccine, Live 1.2.3 Swine Atrophic Rhinitis Vaccine, Inactivated 1.3 Swine Atrophic Rhinitis Vaccine Segment by Downstream 1.3.1 Global Swine Atrophic Rhinitis Vaccine Sales Comparison by Downstream: (2022-2028) 1.3.2 Farms 1.3.3 Individual 1.4 Global Swine Atrophic Rhinitis Vaccine Market Size Estimates and Forecasts 1.4.1 Global Swine Atrophic Rhinitis Vaccine Revenue 2017-2028 1.4.2 Global Swine Atrophic Rhinitis Vaccine Sales 2017-2028 1.4.3 Swine Atrophic Rhinitis Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028 2 Swine Atrophic Rhinitis Vaccine Market Competition by Manufacturers 2.1 Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Manufacturers (2017-2022) 2.2 Global Swine Atrophic Rhinitis Vaccine Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Swine Atrophic Rhinitis Vaccine Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Swine Atrophic Rhinitis Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Swine Atrophic Rhinitis Vaccine Market Competitive Situation and Trends 2.5.1 Swine Atrophic Rhinitis Vaccine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Swine Atrophic Rhinitis Vaccine Players Market Share by Revenue 2.5.3 Global Swine Atrophic Rhinitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Swine Atrophic Rhinitis Vaccine Retrospective Market Scenario by Region 3.1 Global Swine Atrophic Rhinitis Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Swine Atrophic Rhinitis Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Swine Atrophic Rhinitis Vaccine Market Facts & Figures by Country 3.3.1 North America Swine Atrophic Rhinitis Vaccine Sales by Country 3.3.2 North America Swine Atrophic Rhinitis Vaccine Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Swine Atrophic Rhinitis Vaccine Market Facts & Figures by Country 3.4.1 Europe Swine Atrophic Rhinitis Vaccine Sales by Country 3.4.2 Europe Swine Atrophic Rhinitis Vaccine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Swine Atrophic Rhinitis Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Swine Atrophic Rhinitis Vaccine Sales by Region 3.5.2 Asia Pacific Swine Atrophic Rhinitis Vaccine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Swine Atrophic Rhinitis Vaccine Market Facts & Figures by Country 3.6.1 Latin America Swine Atrophic Rhinitis Vaccine Sales by Country 3.6.2 Latin America Swine Atrophic Rhinitis Vaccine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Swine Atrophic Rhinitis Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Swine Atrophic Rhinitis Vaccine Sales by Country 3.7.2 Middle East and Africa Swine Atrophic Rhinitis Vaccine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Swine Atrophic Rhinitis Vaccine Historic Market Analysis by Activity 4.1 Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Activity (2017-2022) 4.2 Global Swine Atrophic Rhinitis Vaccine Revenue Market Share by Activity (2017-2022) 4.3 Global Swine Atrophic Rhinitis Vaccine Price by Activity (2017-2022) 5 Global Swine Atrophic Rhinitis Vaccine Historic Market Analysis by Downstream 5.1 Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Downstream (2017-2022) 5.2 Global Swine Atrophic Rhinitis Vaccine Revenue Market Share by Downstream (2017-2022) 5.3 Global Swine Atrophic Rhinitis Vaccine Price by Downstream (2017-2022) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Pfizer Swine Atrophic Rhinitis Vaccine Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Boehringer Ingelheim 6.2.1 Boehringer Ingelheim Corporation Information 6.2.2 Boehringer Ingelheim Description and Business Overview 6.2.3 Boehringer Ingelheim Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Boehringer Ingelheim Swine Atrophic Rhinitis Vaccine Product Portfolio 6.2.5 Boehringer Ingelheim Recent Developments/Updates 6.3 Bayer 6.3.1 Bayer Corporation Information 6.3.2 Bayer Description and Business Overview 6.3.3 Bayer Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Bayer Swine Atrophic Rhinitis Vaccine Product Portfolio 6.3.5 Bayer Recent Developments/Updates 6.4 Elanco 6.4.1 Elanco Corporation Information 6.4.2 Elanco Description and Business Overview 6.4.3 Elanco Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Elanco Swine Atrophic Rhinitis Vaccine Product Portfolio 6.4.5 Elanco Recent Developments/Updates 6.5 MSD 6.5.1 MSD Corporation Information 6.5.2 MSD Description and Business Overview 6.5.3 MSD Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.5.4 MSD Swine Atrophic Rhinitis Vaccine Product Portfolio 6.5.5 MSD Recent Developments/Updates 6.6 Cahic 6.6.1 Cahic Corporation Information 6.6.2 Cahic Description and Business Overview 6.6.3 Cahic Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Cahic Swine Atrophic Rhinitis Vaccine Product Portfolio 6.6.5 Cahic Recent Developments/Updates 6.7 Ringpu 6.6.1 Ringpu Corporation Information 6.6.2 Ringpu Description and Business Overview 6.6.3 Ringpu Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Ringpu Swine Atrophic Rhinitis Vaccine Product Portfolio 6.7.5 Ringpu Recent Developments/Updates 6.8 Baoling 6.8.1 Baoling Corporation Information 6.8.2 Baoling Description and Business Overview 6.8.3 Baoling Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Baoling Swine Atrophic Rhinitis Vaccine Product Portfolio 6.8.5 Baoling Recent Developments/Updates 6.9 Jizhong 6.9.1 Jizhong Corporation Information 6.9.2 Jizhong Description and Business Overview 6.9.3 Jizhong Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Jizhong Swine Atrophic Rhinitis Vaccine Product Portfolio 6.9.5 Jizhong Recent Developments/Updates 6.10 Dahuanong 6.10.1 Dahuanong Corporation Information 6.10.2 Dahuanong Description and Business Overview 6.10.3 Dahuanong Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Dahuanong Swine Atrophic Rhinitis Vaccine Product Portfolio 6.10.5 Dahuanong Recent Developments/Updates 6.11 Pulike Biology 6.11.1 Pulike Biology Corporation Information 6.11.2 Pulike Biology Swine Atrophic Rhinitis Vaccine Description and Business Overview 6.11.3 Pulike Biology Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Pulike Biology Swine Atrophic Rhinitis Vaccine Product Portfolio 6.11.5 Pulike Biology Recent Developments/Updates 6.12 Tecon 6.12.1 Tecon Corporation Information 6.12.2 Tecon Swine Atrophic Rhinitis Vaccine Description and Business Overview 6.12.3 Tecon Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Tecon Swine Atrophic Rhinitis Vaccine Product Portfolio 6.12.5 Tecon Recent Developments/Updates 6.13 Zhonghai Biotech 6.13.1 Zhonghai Biotech Corporation Information 6.13.2 Zhonghai Biotech Swine Atrophic Rhinitis Vaccine Description and Business Overview 6.13.3 Zhonghai Biotech Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Zhonghai Biotech Swine Atrophic Rhinitis Vaccine Product Portfolio 6.13.5 Zhonghai Biotech Recent Developments/Updates 6.14 EBVAC 6.14.1 EBVAC Corporation Information 6.14.2 EBVAC Swine Atrophic Rhinitis Vaccine Description and Business Overview 6.14.3 EBVAC Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.14.4 EBVAC Swine Atrophic Rhinitis Vaccine Product Portfolio 6.14.5 EBVAC Recent Developments/Updates 6.15 China Institute of Veterinary Medicine 6.15.1 China Institute of Veterinary Medicine Corporation Information 6.15.2 China Institute of Veterinary Medicine Swine Atrophic Rhinitis Vaccine Description and Business Overview 6.15.3 China Institute of Veterinary Medicine Swine Atrophic Rhinitis Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.15.4 China Institute of Veterinary Medicine Swine Atrophic Rhinitis Vaccine Product Portfolio 6.15.5 China Institute of Veterinary Medicine Recent Developments/Updates 7 Swine Atrophic Rhinitis Vaccine Manufacturing Cost Analysis 7.1 Swine Atrophic Rhinitis Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Swine Atrophic Rhinitis Vaccine 7.4 Swine Atrophic Rhinitis Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Swine Atrophic Rhinitis Vaccine Distributors List 8.3 Swine Atrophic Rhinitis Vaccine Customers 9 Swine Atrophic Rhinitis Vaccine Market Dynamics 9.1 Swine Atrophic Rhinitis Vaccine Industry Trends 9.2 Swine Atrophic Rhinitis Vaccine Market Drivers 9.3 Swine Atrophic Rhinitis Vaccine Market Challenges 9.4 Swine Atrophic Rhinitis Vaccine Market Restraints 10 Global Market Forecast 10.1 Swine Atrophic Rhinitis Vaccine Market Estimates and Projections by Activity 10.1.1 Global Forecasted Sales of Swine Atrophic Rhinitis Vaccine by Activity (2023-2028) 10.1.2 Global Forecasted Revenue of Swine Atrophic Rhinitis Vaccine by Activity (2023-2028) 10.2 Swine Atrophic Rhinitis Vaccine Market Estimates and Projections by Downstream 10.2.1 Global Forecasted Sales of Swine Atrophic Rhinitis Vaccine by Downstream (2023-2028) 10.2.2 Global Forecasted Revenue of Swine Atrophic Rhinitis Vaccine by Downstream (2023-2028) 10.3 Swine Atrophic Rhinitis Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Swine Atrophic Rhinitis Vaccine by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Swine Atrophic Rhinitis Vaccine by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Swine Atrophic Rhinitis Vaccine Sales Growth Rate Comparison by Activity (2022-2028) & (Box) & (US$ Million) Table 2. Global Swine Atrophic Rhinitis Vaccine Sales Growth Rate Comparison by Downstream (2022-2028) & (Box) & (US$ Million) Table 3. Global Swine Atrophic Rhinitis Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Swine Atrophic Rhinitis Vaccine Market Competitive Situation by Manufacturers in 2021 Table 5. Global Swine Atrophic Rhinitis Vaccine Sales (Box) of Key Manufacturers (2017-2022) Table 6. Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Manufacturers (2017-2022) Table 7. Global Swine Atrophic Rhinitis Vaccine Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Swine Atrophic Rhinitis Vaccine Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Swine Atrophic Rhinitis Vaccine Average Price (US$/Box) of Key Manufacturers (2017-2022) Table 10. Manufacturers Swine Atrophic Rhinitis Vaccine Manufacturing Sites and Area Served Table 11. Manufacturers Swine Atrophic Rhinitis Vaccine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Swine Atrophic Rhinitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Swine Atrophic Rhinitis Vaccine as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Swine Atrophic Rhinitis Vaccine Sales by Region (2017-2022) & (Box) Table 16. Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Region (2017-2022) Table 17. Global Swine Atrophic Rhinitis Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Swine Atrophic Rhinitis Vaccine Revenue Market Share by Region (2017-2022) Table 19. North America Swine Atrophic Rhinitis Vaccine Sales by Country (2017-2022) & (Box) Table 20. North America Swine Atrophic Rhinitis Vaccine Sales Market Share by Country (2017-2022) Table 21. North America Swine Atrophic Rhinitis Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Swine Atrophic Rhinitis Vaccine Revenue Market Share by Country (2017-2022) Table 23. Europe Swine Atrophic Rhinitis Vaccine Sales by Country (2017-2022) & (Box) Table 24. Europe Swine Atrophic Rhinitis Vaccine Sales Market Share by Country (2017-2022) Table 25. Europe Swine Atrophic Rhinitis Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Swine Atrophic Rhinitis Vaccine Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Swine Atrophic Rhinitis Vaccine Sales by Region (2017-2022) & (Box) Table 28. Asia Pacific Swine Atrophic Rhinitis Vaccine Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Swine Atrophic Rhinitis Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Swine Atrophic Rhinitis Vaccine Revenue Market Share by Region (2017-2022) Table 31. Latin America Swine Atrophic Rhinitis Vaccine Sales by Country (2017-2022) & (Box) Table 32. Latin America Swine Atrophic Rhinitis Vaccine Sales Market Share by Country (2017-2022) Table 33. Latin America Swine Atrophic Rhinitis Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Swine Atrophic Rhinitis Vaccine Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Swine Atrophic Rhinitis Vaccine Sales by Country (2017-2022) & (Box) Table 36. Middle East and Africa Swine Atrophic Rhinitis Vaccine Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Swine Atrophic Rhinitis Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Swine Atrophic Rhinitis Vaccine Revenue Market Share by Country (2017-2022) Table 39. Global Swine Atrophic Rhinitis Vaccine Sales by Activity (2017-2022) & (Box) Table 40. Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Activity (2017-2022) Table 41. Global Swine Atrophic Rhinitis Vaccine Revenue by Activity (2017-2022) & (US$ Million) Table 42. Global Swine Atrophic Rhinitis Vaccine Revenue Share by Activity (2017-2022) Table 43. Global Swine Atrophic Rhinitis Vaccine Price by Activity (2017-2022) & (US$/Box) Table 44. Global Swine Atrophic Rhinitis Vaccine Sales (Box) by Downstream (2017-2022) Table 45. Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Downstream (2017-2022) Table 46. Global Swine Atrophic Rhinitis Vaccine Revenue by Downstream (2017-2022) & (US$ Million) Table 47. Global Swine Atrophic Rhinitis Vaccine Revenue Share by Downstream (2017-2022) Table 48. Global Swine Atrophic Rhinitis Vaccine Price by Downstream (2017-2022) & (US$/Box) Table 49. Pfizer Corporation Information Table 50. Pfizer Description and Business Overview Table 51. Pfizer Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 52. Pfizer Swine Atrophic Rhinitis Vaccine Product Table 53. Pfizer Recent Developments/Updates Table 54. Boehringer Ingelheim Corporation Information Table 55. Boehringer Ingelheim Description and Business Overview Table 56. Boehringer Ingelheim Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 57. Boehringer Ingelheim Swine Atrophic Rhinitis Vaccine Product Table 58. Boehringer Ingelheim Recent Developments/Updates Table 59. Bayer Corporation Information Table 60. Bayer Description and Business Overview Table 61. Bayer Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 62. Bayer Swine Atrophic Rhinitis Vaccine Product Table 63. Bayer Recent Developments/Updates Table 64. Elanco Corporation Information Table 65. Elanco Description and Business Overview Table 66. Elanco Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 67. Elanco Swine Atrophic Rhinitis Vaccine Product Table 68. Elanco Recent Developments/Updates Table 69. MSD Corporation Information Table 70. MSD Description and Business Overview Table 71. MSD Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 72. MSD Swine Atrophic Rhinitis Vaccine Product Table 73. MSD Recent Developments/Updates Table 74. Cahic Corporation Information Table 75. Cahic Description and Business Overview Table 76. Cahic Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 77. Cahic Swine Atrophic Rhinitis Vaccine Product Table 78. Cahic Recent Developments/Updates Table 79. Ringpu Corporation Information Table 80. Ringpu Description and Business Overview Table 81. Ringpu Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 82. Ringpu Swine Atrophic Rhinitis Vaccine Product Table 83. Ringpu Recent Developments/Updates Table 84. Baoling Corporation Information Table 85. Baoling Description and Business Overview Table 86. Baoling Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 87. Baoling Swine Atrophic Rhinitis Vaccine Product Table 88. Baoling Recent Developments/Updates Table 89. Jizhong Corporation Information Table 90. Jizhong Description and Business Overview Table 91. Jizhong Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 92. Jizhong Swine Atrophic Rhinitis Vaccine Product Table 93. Jizhong Recent Developments/Updates Table 94. Dahuanong Corporation Information Table 95. Dahuanong Description and Business Overview Table 96. Dahuanong Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 97. Dahuanong Swine Atrophic Rhinitis Vaccine Product Table 98. Dahuanong Recent Developments/Updates Table 99. Pulike Biology Corporation Information Table 100. Pulike Biology Description and Business Overview Table 101. Pulike Biology Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 102. Pulike Biology Swine Atrophic Rhinitis Vaccine Product Table 103. Pulike Biology Recent Developments/Updates Table 104. Tecon Corporation Information Table 105. Tecon Description and Business Overview Table 106. Tecon Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 107. Tecon Swine Atrophic Rhinitis Vaccine Product Table 108. Tecon Recent Developments/Updates Table 109. Zhonghai Biotech Corporation Information Table 110. Zhonghai Biotech Description and Business Overview Table 111. Zhonghai Biotech Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 112. Zhonghai Biotech Swine Atrophic Rhinitis Vaccine Product Table 113. Zhonghai Biotech Recent Developments/Updates Table 114. EBVAC Corporation Information Table 115. EBVAC Description and Business Overview Table 116. EBVAC Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 117. EBVAC Swine Atrophic Rhinitis Vaccine Product Table 118. EBVAC Recent Developments/Updates Table 119. China Institute of Veterinary Medicine Corporation Information Table 120. China Institute of Veterinary Medicine Description and Business Overview Table 121. China Institute of Veterinary Medicine Swine Atrophic Rhinitis Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022) Table 122. China Institute of Veterinary Medicine Swine Atrophic Rhinitis Vaccine Product Table 123. China Institute of Veterinary Medicine Recent Developments/Updates Table 124. Production Base and Market Concentration Rate of Raw Material Table 125. Key Suppliers of Raw Materials Table 126. Swine Atrophic Rhinitis Vaccine Distributors List Table 127. Swine Atrophic Rhinitis Vaccine Customers List Table 128. Swine Atrophic Rhinitis Vaccine Market Trends Table 129. Swine Atrophic Rhinitis Vaccine Market Drivers Table 130. Swine Atrophic Rhinitis Vaccine Market Challenges Table 131. Swine Atrophic Rhinitis Vaccine Market Restraints Table 132. Global Swine Atrophic Rhinitis Vaccine Sales Forecast by Activity (2023-2028) & (Box) Table 133. Global Swine Atrophic Rhinitis Vaccine Sales Market Share Forecast by Activity (2023-2028) Table 134. Global Swine Atrophic Rhinitis Vaccine Revenue Forecast by Activity (2023-2028) & (US$ Million) Table 135. Global Swine Atrophic Rhinitis Vaccine Revenue Market Share Forecast by Activity (2023-2028) Table 136. Global Swine Atrophic Rhinitis Vaccine Sales Forecast by Downstream (2023-2028) & (Box) Table 137. Global Swine Atrophic Rhinitis Vaccine Sales Market Share Forecast by Downstream (2023-2028) Table 138. Global Swine Atrophic Rhinitis Vaccine Revenue Forecast by Downstream (2023-2028) & (US$ Million) Table 139. Global Swine Atrophic Rhinitis Vaccine Revenue Market Share Forecast by Downstream (2023-2028) Table 140. Global Swine Atrophic Rhinitis Vaccine Sales Forecast by Region (2023-2028) & (Box) Table 141. Global Swine Atrophic Rhinitis Vaccine Sales Market Share Forecast by Region (2023-2028) Table 142. Global Swine Atrophic Rhinitis Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million) Table 143. Global Swine Atrophic Rhinitis Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Swine Atrophic Rhinitis Vaccine Figure 2. Global Swine Atrophic Rhinitis Vaccine Market Share by Activity in 2021 & 2028 Figure 3. Swine Atrophic Rhinitis Vaccine, Live Product Picture Figure 4. Swine Atrophic Rhinitis Vaccine, Inactivated Product Picture Figure 5. Global Swine Atrophic Rhinitis Vaccine Market Share by Downstream in 2021 & 2028 Figure 6. Farms Figure 7. Individual Figure 8. Global Swine Atrophic Rhinitis Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 9. Global Swine Atrophic Rhinitis Vaccine Market Size (2017-2028) & (US$ Million) Figure 10. Global Swine Atrophic Rhinitis Vaccine Sales (2017-2028) & (Box) Figure 11. Swine Atrophic Rhinitis Vaccine Sales Share by Manufacturers in 2021 Figure 12. Global Swine Atrophic Rhinitis Vaccine Revenue Share by Manufacturers in 2021 Figure 13. The Global 5 and 10 Largest Swine Atrophic Rhinitis Vaccine Players: Market Share by Revenue in 2021 Figure 14. Swine Atrophic Rhinitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 15. Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Region (2017-2022) Figure 16. Global Swine Atrophic Rhinitis Vaccine Sales Market Share by Region in 2021 Figure 17. Global Swine Atrophic Rhinitis Vaccine Revenue Market Share by Region (2017-2022) Figure 18. Global Swine Atrophic Rhinitis Vaccine Revenue Market Share by Region in 2021 Figure 19. United States Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 20. Canada Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Germany Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. France Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. U.K. Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Italy Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Russia Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. China Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Japan Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. South Korea Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. India Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Australia Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. China Taiwan Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Indonesia Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Thailand Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Malaysia Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Mexico Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Brazil Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Argentina Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Turkey Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Saudi Arabia Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. UAE Swine Atrophic Rhinitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Sales Market Share of Swine Atrophic Rhinitis Vaccine by Activity (2017-2022) Figure 42. Manufacturing Cost Structure of Swine Atrophic Rhinitis Vaccine Figure 43. Manufacturing Process Analysis of Swine Atrophic Rhinitis Vaccine Figure 44. Swine Atrophic Rhinitis Vaccine Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Pfizer Boehringer Ingelheim Bayer Elanco MSD Cahic Ringpu Baoling Jizhong Dahuanong Pulike Biology Tecon Zhonghai Biotech EBVAC China Institute of Veterinary Medicine